NA Selank Amidate

Amidate de Selank NA

Amidate de Selank NA

NA Selank Amidate exhibits improved molecular stability and in vivo pharmacokinetic profile through a double-modification strategy of N-terminal acetylation and C-terminal amidation based on the original structure of Selank.

 

UGS: 198884 Catégorie:
Partagez votre amour

NA Selank Amidate exhibits improved molecular stability and in vivo pharmacokinetic profile through a double-modification strategy of N-terminal acétylation and C-terminal amidation based on the original structure of Selank.

This results in an increased half-life, amélioré barrière hémato-encéphalique penetration efficiency, and prolonged bioactivity in both molecular and animal models.

De plus, NA Selank Amidate exhibits potent immunomodulation and anti-stress activity.

Séquence

ac-thr-lys-pro-arg-pro-gly-pro-nh2

Numéro CAS

/

Formule moléculaire

C35H60N12O9

Poids moléculaire

792.94

Research Of NA Selank Amidate

1.Retained and Enhanced Efficacy

En termes d'efficacité,NA Selank Amidate retains all of the characteristics of Selank, regulating gamma-aminobutyric acid (GABA) neurotransmission in the brain while also modulating the dopaminergic et serotonergic systems to deliver outstanding anxiolytique et antidepressant effets.

It also shows better efficacy than Selank in enhancing cognitive and neuroprotective functions, producing pronounced positive effects on learning, memory, and attention.

2.Anxiolytic and Mood-Stabilizing Effects

In a concentration-dependent and subtype-selective manner, Amidate de Selank NA allosterically modulates le GABA-A receptor by potentiating the binding efficacy of GABA to its receptor or enhancing chloride ion channel opening efficiency.

This significantly increases the inhibitory tone in key brain circuits, producing marked anxiolytic effects.

En outre, the side effects of this anxiolytic action are significantly milder than those of conventional anxiolytic drugs, making NA Selank Amidate a more attractive mood-stabilizing compound.

3.Cognitive Enhancement and Neuroprotection

NA Selank Amidate directly activates BDNF gene transcription by inducing phosphorylation of the promoter-located CREB transcription factor and acetylation of histone H3, increasing BDNF ARNm levels 3.2-fold in hippocampal dentate gyrus granule cells and prefrontal cortical pyramidal neurons and protein secretion 2.8-fold within 24 heures.

This activates the TrkB receptor signaling pathway downstream, inducing the Ras-MAPK and PI3K-Acte cascade to increase dendritic spine density by 39%, upregulate synaptophysin expression by 45%, and restore LTP amplitude to baseline.

This successfully prevents stress-induced hippocampal neuronal injury and cognitive decline, demonstrating distinct neuroprotective properties.

4.Immunomodulatory and Anti-Stress Effects

NA Selank Amidate is a competitive inhibitor of enkephalin-degrading enzyme, protecting endogenous peptides opioïdes depuis hydrolyse and thereby elevating their levels, while it inhibits LPS (lipopolysaccharide)-induced expression of pro-inflammatory cytokines y compris IL-6 et TNF-α by 40–60% in astrocytes.

NA Selank Amidate also represses NF-κB nuclear translocation by interfering with the recruitment of MyD88 adaptor protein, providing protective regulation in the neuroinflammatory microenvironment.

COA

HPLC

MS

(1) Doyno, C. R.; Blanc, C. M. Agents sédatifs-hypnotiques qui ont un impact sur les récepteurs de l'acide gamma-aminobutyrique: Focus sur le flunitrazépam, Acide gamma-hydroxybutyrique, Phénibut, and Selank. J Clin Pharmacol 2021, 61 Supplément 2, S114-S128. DOI: 10.1002/jcph.1922 From NLM M

(2) La pauvre, UN.; Kolomine, T.; Andreeva, L.; Bondarenko, E.; Myassoedov, N.; Slominsky, P.; Shadrina, M. Le peptide Selank améliore l'effet du diazépam sur la réduction de l'anxiété dans des conditions de stress léger et chronique imprévisibles chez le rat. Comportement Neurol 2017, 2017, 50910

(3) Épingle, L. G.; Nadorova, UN. V.; Antipova, T. UN.; Kruglov, S. V.; Koudrine, V. S.; Durnev, UN. D. Selank, Analogue peptidique de la tuftsine, Protège contre les troubles de la mémoire induits par l'éthanol en régulant le contenu en BDNF dans l'hippocampe et le cortex préfrontal

(4) Épingle, L. G.; Nadorova, UN. V.; Seredénine, S. B. Selank inhibe l'hyperlocomotion induite par l'éthanol et la manifestation de sensibilisation comportementale chez les souris DBA/2. Bull Exp Biol Med 2016, 162 (1), 56-59. DOI: 10.1007/s10517-016-3544-6 From NLM Medline.

(5) Coût, N. V.; Sokolov, O.; Gabaïeva, M. V.; Grivennikov, je. UN.; Andreeva, L. UN.; Miasoedov, N. F.; Zozulie, UN. UN. [Semax et Selank inhibent les enzymes dégradant l'enképhaline du sérum humain]]. Bioorg Khim 2001, 27 (3), 180-183. DOI: 10.1023/un:10113730028

(6) Je ne sais pas, G. G.; Teleshova, E. S.; Botchkarev, V. K.; Kochtchelev, V. V.; Syouniakov, T. S. P.3.036 Nouveau Selank anxiolytique: Résultats des essais cliniques de Phase II. Neuropsychopharmacologie européenne 2005, 15, S159-S160. DOI: 10.1016/s0924-977x(05)80332-3.

(7) Slominsky, P.. UN.; Shadrina, M. JE.; Kolomine, T. UN.; Stavrovskaïa, UN. V.; Filatova, E. V.; Andreeva, L. UN.; Illarioshkine, S. N.; Myassoedov, N. F. Les peptides semax et selank affectent le comportement des rats atteints d'un parkinsonisme de type PD induit par la 6-OHDA. Jusqu'au Biol Sc

(8) Sollertinskaja, T. N.; Chorokhov, M. V.; Myassoedov, N. F. Les effets cérébroprotecteurs de Semax et Selank chez les primates atteints de différents types de névroses. Revue internationale de psychophysiologie 2008, 69 (3). DOI: 10.1016/j.ijpsycho.2008.05.356.

Séquence:

ac-thr-lys-pro-arg-pro-gly-pro-nh2

CAS:

/

M.W.:

792.94 g/mole

Maison Recherche WhatsApp Services Produit